The first week of September has seen major pharmacy chains across the United States roll out the nation's first over-the-counter…
A September 1 report from the Centers for Disease Control and Prevention found that overdose deaths involving counterfeit pharmaceutical pills…
The Food and Drug Administration has approved the first generic versions of Vyvanse, the prescription stimulant known for being "abuse-deterrent."…
California's contingency management (CM) program is slowly getting off the ground, following the Medi-Cal expansion in 2022 that allowed the…
On August 25, the New York Office of Public Safety held a briefing ahead of International Overdose Awareness Day. It…
On July 19, the National Institute on Drug Abuse awarded over $4.3 million to InterveXion Therapeutics, an Arkansas-based biopharmaceutical company…
If any of you use stimulants and have a particularly good system for waking up on time, I wouldn’t mind…
When someone dies without a doctor present, and they hadn't seen a doctor anytime recently, a local medical examiner will…
Rhode Island’s first safe consumption site (SCS) is expected to open in Providence in early 2024. If approved by the…
On April 12, the White House Office of National Drug Control Policy (ONDCP) formally designated xylazine, in combination with fentanyl,…